- About us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Professionnels de la santé
- Care
- Research
- Our research teams
- Molecular pathology
- Functional precision medicine for leukemia
- Normal and pathological hematopoiesis
- Niche, Cancer, and Radiation in Hematopoiesis
- Population Evolution and Interaction Particle Systems
- Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Identification and targeting of extrinsic regulators of myeloid malignancies
- Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Molecular Mechanisms of Acute Myeloid Leukemia Development
- Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Leukemia & Niche Dynamics
- Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Stem cell dysfunction and secondary AML
- Biostatistics and clinical epidemiology
- Our technological platforms
Curing leukemia
at all stages of life
The pathologies treated
Acute Lymphoblastic Leukemias
Acute Myeloid Leukemias
Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Leukemia Predisposition Syndromes
Acquired and Constitutional Bone Marrow Aplasias
Acute Lymphoblastic Leukemias
Acute Myeloid Leukemias
Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Leukemia Predisposition Syndromes
Acquired and Constitutional Bone Marrow Aplasias
The Leukemia Institute in figures
1stLeukemia Treatment and Research Center
Research Teams
14Clinical Departments
80Ongoing Clinical Trials
In just a few clicks
Organize patient care
10 clinical departments dedicated to children, adolescents, adults, and seniors
Explore our research areas
16 research teams covering fundamental, translational, clinical research and care pathway improvement
Explore our training programs
A unique training offer for students, researchers, healthcare professionals, and industry partners
Become an industry partner
Innovative patents and industrial collaborations, including through our drug screening platform
Our featured research projects
Intrinsic and Extrinsic Effects of the Immune Microenvironment in Myelodysplastic Syndromes
This project employs in vitro and ex vivo models to decipher how stromal and blast cells alter bone marrow NK cell-mediated immunosurveillance during MDS initiation and progression.
Nicolas Dulphy / Valéria Bisio
E-selectin Antagonists in Leukemia
Evaluation of molecules to block leukemia-microenvironment interaction and restore chemosensitivity.
Julien Calvo
Targeting the myeloid-specific isoform PIK3CG using heterobifunctional PROTAC-type degrader molecules to block AML progression.
Lois Kelly
Host foundation and founding members
Suivez nos actions en vous inscrivant à la lettre d'information de l’institut
- Become an expert patient
- To be cared for and supported
- Patients and relatives